The company
Genmab A/S - American Depositary Shares
GMAB · Nasdaq
GMAB stood above a rising 150-day average in 24 of the last 52 weekly readings, including each of the last 6 weeks. It is 30.2% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 6 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 13
- Institutions holding
- 279 (+19)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 24 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
13 disclosed lines: House 10, Senate 3, executive 0; 4 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Alan Armstrong Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 30 Mar 2026filed 21 Jul 2026 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 16 Jan 2025filed 10 Feb 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 16 Dec 2024filed 14 Jan 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 19 Jul 2024filed 15 Aug 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 18 Jun 2024filed 9 Jul 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 16 Oct 2023filed 11 Nov 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 15 Sep 2023filed 15 Oct 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 20 Jul 2023filed 21 Aug 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 19 Jul 2023filed 21 Aug 2023 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $50k–$100k | 10 Jul 2023filed 13 Aug 2023 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $1k–$15k | 31 Mar 2023filed 17 Apr 2023 |
| Thomas R. Carper Senate: U.S. Senate eFDSenator | boughtspouse | $1k–$15k | 20 Nov 2020filed 17 May 2021 |
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Paradigm Biocapital Advisors LPadded · filed 14 Aug 2026 | 13,133,131$360.8M | +5,165,295+64.8% |
| Orbis Allan Gray Ltdreduced · filed 14 Aug 2026 | 11,368,161$312.3M | -1,557,417−12.0% |
| ALLIANCEBERNSTEIN L.P.reduced · filed 14 Aug 2026 | 8,644,877$231.9M | -912,272−9.5% |
| DEERFIELD MANAGEMENT COMPANY, L.P.added · filed 14 Aug 2026 | 6,865,000$188.6M | +4,403,000+178.8% |
| Deep Track Capital, LPadded · filed 14 Aug 2026 | 5,650,000$155.2M | +1,986,750+54.2% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIPunchanged · filed 13 Aug 2026 | 4,975,324$136.7M | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 4,671,252$128.3M | +134,687+3.0% |
| Sofinnova Investments, Inc.added · filed 14 Aug 2026 | 4,045,215$111.1M | +3,292,954+437.7% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 3,517,850$96.6M | -896,700−20.3% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 3,506,843$96.3M | +1,167,411+49.9% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
No ratio computed from its SEC filings yet.
Analyst forecasts
No analyst forecasts yet.